Impel Pharmaceuticals Income Tax

As of the most recent data (September 2023), IMPL shows a income tax of $11M. That compares with $2K in the prior-year period — up 549950.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMPL's income tax is now $11M (was $2K) — a 549950.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Impel Pharmaceuticals is outperforming or lagging.

Tracking IMPL's income tax over time shows whether Impel Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $11M That compares with $2K in the prior-year period — up 549950.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this income tax page, Stockcircle has Impel Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect income tax (currently $11M) with ownership activity and broader fundamentals.

Impel Pharmaceuticals's income tax is $11M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.